Millennium Management’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,480
Closed -$60.8K 6398
2025
Q2
$60.8K Sell
22,480
-5,924
-21% -$15.7K ﹤0.01% 5586
2025
Q1
$149K Sell
28,404
-13,960
-33% -$88.2K ﹤0.01% 5366
2024
Q4
$325K Sell
42,364
-504
-1% -$4.22K ﹤0.01% 5027
2024
Q3
$401K Sell
42,868
-14,628
-25% -$141K ﹤0.01% 5002
2024
Q2
$616K Buy
57,496
+32,899
+134% +$446K ﹤0.01% 4456
2024
Q1
$364K Buy
24,597
+20,151
+453% +$281K ﹤0.01% 5019
2023
Q4
$85K Buy
+4,446
New +$109K ﹤0.01% 5381
2023
Q3
Sell
-1,268
Closed -$57.4K 6494
2023
Q2
$57.4K Buy
+1,268
New +$62.1K ﹤0.01% 5446
2022
Q3
Sell
-2,274
Closed -$137K 7421
2022
Q2
$137K Sell
2,274
-862
-27% -$64.8K ﹤0.01% 5802
2022
Q1
$175K Buy
+3,136
New +$259K ﹤0.01% 5885
2021
Q4
Sell
-7,655
Closed -$1.08M 7299
2021
Q3
$1.08M Buy
+7,655
New +$898K ﹤0.01% 4595

Other funds holding RLYB

Millennium Management's RLYB Position: Q3 2025 in Review

Millennium Management sold out of Rallybio (RLYB) in Q3 2025, closing a stake of 22,480 shares — an estimated $60.8K sold.

Millennium Management first reported a position in RLYB in Q3 2021 and held it in 11 quarters. The position peaked at $1.08M in Q3 2021. 45 funds tracked by Wall St. Rank hold RLYB as of Q3 2025.

  • Millennium Management reported no remaining Rallybio position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 22,480 Rallybio shares in Q3 2025, an estimated $60.8K.
  • Millennium Management first reported a position in Rallybio in Q3 2021 and held it in 11 quarters.
  • Millennium Management's Rallybio position peaked at $1.08M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Rallybio as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.